MAH Market authorisation holder MHRA Medicines and Healthcare products Regulatory Agency (UK) MR Mutual recognition procedure (EU) µg micrograms µg/hr micrograms per hour mEq milli-equivalents mg milligram mg/h milligrams per h MRHD maximum recommended human dose NRS Numeric Rating Scale (11 point NRS for pain) 0 = no pain, 11 = pain as bad as you can imagine NSAID Non-Steroidal Anti-Inflammatory Drug PD Pharmacodynamics PI Product information PK Pharmacokinetic PP Per protocol pg picogram pg/mL picogram per millilitre PSURs Periodic safety update reports QT QT interval for rate QTc QT interval corrected for heart rate QTci QT interval individually corrected RR relative risk SADR serious adverse drug reaction SAE serious adverse event SD standard of the mean SL Sublingual
MAH Market authorisation holder MHRA Medicines and Healthcare products Regulatory Agency (UK) MR Mutual recognition procedure (EU) µg micrograms µg/hr micrograms per hour mEq milli-equivalents mg milligram mg/h milligrams per h MRHD maximum recommended human dose NRS Numeric Rating Scale (11 point NRS for pain) 0 = no pain, 11 = pain as bad as you can imagine NSAID Non-Steroidal Anti-Inflammatory Drug PD Pharmacodynamics PI Product information PK Pharmacokinetic PP Per protocol pg picogram pg/mL picogram per millilitre PSURs Periodic safety update reports QT QT interval for rate QTc QT interval corrected for heart rate QTci QT interval individually corrected RR relative risk SADR serious adverse drug reaction SAE serious adverse event SD standard of the mean SL Sublingual
auspar-buprenorphine-161213.docx